- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/01 - DNA viruses
Patent holdings for IPC class C07K 14/01
Total number of patents in this class: 312
10-year publication summary
|
10
|
17
|
16
|
17
|
11
|
25
|
16
|
33
|
15
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Flagship Pioneering Innovations V, Inc. | 223 |
9 |
| Deutsches Krebsforschungszentrum | 419 |
6 |
| The University of North Carolina at Chapel Hill | 2033 |
6 |
| The Institute of Biophysics of The Chinese Academy of Sciences | 11 |
6 |
| Guangdong Lanyu Biotechnology Co., Ltd. | 6 |
6 |
| ContraFect Corporation | 72 |
5 |
| The General Hospital Corporation | 4733 |
4 |
| Kaneka Corporation | 4522 |
4 |
| Mitsui & Co., Ltd. | 65 |
4 |
| Proclara Biosciences, Inc. | 8 |
4 |
| Rakuno Gakuen University | 15 |
4 |
| Boehringer Ingelheim Vetmedica, Inc. | 112 |
3 |
| The Johns Hopkins University | 5667 |
3 |
| EpiVax, Inc. | 80 |
3 |
| NeuroPhage Pharmaceuticals, Inc. | 5 |
3 |
| ProBioGen AG | 71 |
3 |
| The University of Tokyo | 4176 |
3 |
| Othair Prothena Limited | 29 |
3 |
| The Regents of the University of California | 19918 |
2 |
| Genentech, Inc. | 3976 |
2 |
| Other owners | 229 |